ACADIA Pharmaceuticals Inc. ACAD NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

85/100

5/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour ACADIA Pharmaceuticals Inc. (ACAD), dont 12 achats et 37 ventes. Le total des achats d'initiés s'élève à $614.89K et le total des ventes d'initiés à $2.81M.

Les initiés notables ayant une activité récente comprennent Kihara James, Schneyer Mark C., Rhodes Jennifer J. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — ACAD

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-26	Kihara James	Principal Accounting Officer	Vente Informative	12	$21.73	$260.70	26,885
2026-03-26	Schneyer Mark C.	EVP, Chief Financial Officer	Vente Informative	37	$21.72	$803.54	60,269
2026-03-25	Rhodes Jennifer J	EVP, Chief Legal Officer, Sec	Vente Informative	3,844	$21.47	$82.53K	11,280
2026-03-25	Kihara James	Principal Accounting Officer	Exercice d'Options (Vente)	2,142	-	-	4,284
2026-03-25	Owen Adams Catherine	Chief Executive Officer	Vente Informative	11,641	$21.47	$249.93K	14,803
2026-03-25	Thompson Elizabeth H.z.	EVP, Head of Research & Dev	Vente Informative	3,435	$21.47	$73.75K	3,280
2026-03-25	Schneyer Mark C.	EVP, Chief Financial Officer	Exercice d'Options (Vente)	6,178	-	-	12,358
2026-03-24	Rhodes Jennifer J	EVP, Chief Legal Officer, Sec	Exercice d'Options	7,515	-	-	15,124
2026-03-24	Kihara James	Principal Accounting Officer	Exercice d'Options (Vente)	1,627	-	-	4,883
2026-03-24	Owen Adams Catherine	Chief Executive Officer	Exercice d'Options	23,509	-	-	26,444
2026-03-24	Thompson Elizabeth H.z.	EVP, Head of Research & Dev	Exercice d'Options	6,715	-	-	6,715
2026-03-24	Schneyer Mark C.	EVP, Chief Financial Officer	Exercice d'Options (Vente)	8,138	-	-	24,414
2026-03-06	Rhodes Jennifer J	EVP, Chief Legal Officer, Sec	Attribution de RSU	26,382	-	-	26,382
2026-03-06	Kihara James	Principal Accounting Officer	Attribution de RSU	6,332	-	-	6,332
2026-03-06	Owen Adams Catherine	Chief Executive Officer	Attribution de RSU	76,509	-	-	76,509
2026-03-06	Thompson Elizabeth H.z.	EVP, Head of Research & Dev	Attribution de RSU	29,548	-	-	29,548
2026-03-06	Schneyer Mark C.	EVP, Chief Financial Officer	Attribution de RSU	26,382	-	-	26,382
2026-03-06	Garner Thomas	EVP, Chief Commercial Officer	Attribution de RSU	28,493	-	-	28,493
2026-03-03	Poole Jonathan	Officer	Inconnu	-	-	-	-
2026-03-03	Poole Jonathan	Director	Attribution de RSU	2,010	-	-	2,010
2026-02-09	Rhodes Jennifer J	EVP, Chief Legal Officer, Sec	Vente Informative	6,950	$23.38	$162.49K	7,609
2026-02-06	Rhodes Jennifer J	EVP, Chief Legal Officer, Sec	Exercice d'Options (Vente)	12,944	-	-	12,945
2025-11-18	Kihara James	Principal Accounting Officer	Vente Informative	4,084	$23.69	$96.75K	25,058
2025-11-18	Schneyer Mark C.	EVP, Chief Financial Officer	Vente Informative	10,262	$23.69	$243.11K	53,338
2025-11-17	Kihara James	Principal Accounting Officer	Exercice d'Options (Vente)	3,966	-	-	-
2025-11-17	Schneyer Mark C.	EVP, Chief Financial Officer	Exercice d'Options (Vente)	9,913	-	-	-
2025-11-10	Daly James M	Director	Vente Informative	30,000	$22.37	$670.98K	4,041
2025-09-15	Schneyer Mark C.	EVP, Chief Financial Officer	Vente Informative	3,498	$23.65	$82.73K	43,447
2025-09-12	Schneyer Mark C.	EVP, Chief Financial Officer	Attribution de RSU	6,815	-	-	46,945
2025-09-02	Garofalo Elizabeth A.	Director	Vente Informative	1,600	$25.98	$41.56K	25,382
2025-08-18	Schneyer Mark C.	EVP, Chief Financial Officer	Vente Informative	22,000	$25.18	$554.02K	40,130
2025-06-04	Brege Laura	Director	Vente Informative	14,446	$21.78	$314.63K	15,095
2025-05-29	Harrigan Edmund	Director	Exercice d'Options (Vente)	9,387	-	-	-
2025-05-29	Baker Bros. Advisors Lp	10 Percent Owner	Attribution de RSU	27,586	$22.29	$614.89K	27,586
2025-05-29	Soland Daniel B	Director	Exercice d'Options (Vente)	9,387	-	-	-
2025-05-29	Brege Laura	Director	Exercice d'Options (Vente)	9,387	-	-	-
2025-05-29	Daly James M	Director	Exercice d'Options (Vente)	9,387	-	-	-
2025-05-29	Garofalo Elizabeth A.	Director	Exercice d'Options (Vente)	9,387	-	-	-
2025-05-29	Ndu Adora	Director	Exercice d'Options (Vente)	9,387	-	-	-
2025-05-16	Kihara James	Principal Accounting Officer	Vente Informative	2,000	$20.00	$40K	20,395
2025-05-16	Schneyer Mark C.	EVP, Chief Financial Officer	Vente Informative	2,000	$25.00	$50K	62,130
2025-05-02	Kihara James	Principal Accounting Officer	Vente Informative	1,327	$14.60	$19.37K	23,526
2025-05-02	Schneyer Mark C.	EVP, Chief Financial Officer	Vente Informative	3,498	$14.60	$51.07K	62,773
2025-05-01	Kihara James	Principal Accounting Officer	Exercice d'Options (Vente)	2,596	-	-	5,192
2025-05-01	Schneyer Mark C.	EVP, Chief Financial Officer	Exercice d'Options (Vente)	6,815	-	-	13,630
2025-04-08	Kihara James	Principal Accounting Officer	Vente Informative	1,028	$14.82	$15.23K	22,257
2025-04-08	Schneyer Mark C.	EVP, Chief Financial Officer	Vente Informative	2,708	$14.82	$40.13K	59,456
2025-04-05	Kihara James	Principal Accounting Officer	Exercice d'Options (Vente)	2,010	-	-	2,010
2025-04-05	Schneyer Mark C.	EVP, Chief Financial Officer	Exercice d'Options (Vente)	5,275	-	-	5,276
2025-03-26	Kihara James	Principal Accounting Officer	Vente Informative	1,095	$17.05	$18.67K	21,275

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration